• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球范围内A群链球菌大环内酯类耐药emm型的流行情况、表型及其在过去二十年中的耐药标记基因型的总体概况:一项系统综述。

A global snapshot on the prevalent macrolide-resistant emm types of Group A Streptococcus worldwide, their phenotypes and their resistance marker genotypes during the last two decades: A systematic review.

作者信息

Rafei Rayane, Al Iaali Rayane, Osman Marwan, Dabboussi Fouad, Hamze Monzer

机构信息

Laboratoire Microbiologie Santé et Environnement (LMSE), Doctoral School of Sciences and Technology, Faculty of Public Health, Lebanese University, Tripoli, Lebanon.

Laboratoire Microbiologie Santé et Environnement (LMSE), Doctoral School of Sciences and Technology, Faculty of Public Health, Lebanese University, Tripoli, Lebanon.

出版信息

Infect Genet Evol. 2022 Apr;99:105258. doi: 10.1016/j.meegid.2022.105258. Epub 2022 Feb 24.

DOI:10.1016/j.meegid.2022.105258
PMID:35219865
Abstract

Watchful epidemiological surveillance of macrolide-resistant Group A Streptococcus (MRGAS) clones is important owing to the evolutionary and epidemiological dynamic of GAS. Meanwhile, data on the global distribution of MRGAS emm types according to macrolide resistance phenotypes and genotypes are scant and need to be updated. For this, the present systematic review analyses a global set of extensively characterized MRGAS isolates from patients of diverse ages and clinical presentations over approximately two decades (2000 to 2020) and recaps the peculiar epidemiological features of the dominant MRGAS clones. Based on the inclusion and exclusion criteria, 53 articles (3593 macrolide-resistant and 15,951 susceptible isolates) distributed over 23 countries were dissected with a predominance of high-income countries over low-income ones. Although macrolide resistance in GAS is highly variable in different countries, its within-GAS distribution seems not to be random. emm pattern E, 13 major emm types (emm12, 4, 28, 77, 75, 11, 22, 92, 58, 60, 94, 63, 114) and 4 emm clusters (A-C4, E1, E6, and E2) were significantly associated with macrolide resistance. emm patterns A-C and D, 14 major emm types (emm89, 3, 6, 2, 44, 82, 87, 118, 5, 49, 81, 59, 227, 78) and 3 well-defined emm clusters (A-C5, E3, and D4) were significantly associated with macrolide susceptibility. Scrutinizing the tendency of each MRGAS emm type to be significantly associated with specific macrolide resistance phenotype or genotype, interesting vignettes are also unveiled. The 30-valent vaccine covers ~95% of MRGAS isolates. The presented data urge the importance of comprehensive nationwide sustained surveillance of MRGAS circulating clones particularly in Low and Middle income countries where sampling bias is high and GAS epidemiology is obfuscated and needs to be demystified.

摘要

鉴于A群链球菌(GAS)的进化和流行病学动态,对大环内酯类耐药A群链球菌(MRGAS)克隆进行密切的流行病学监测很重要。与此同时,关于MRGAS emm型根据大环内酯类耐药表型和基因型的全球分布数据很少,需要更新。为此,本系统综述分析了大约二十年间(2000年至2020年)来自不同年龄和临床表现患者的一组全球范围内广泛特征化的MRGAS分离株,并概括了主要MRGAS克隆的独特流行病学特征。根据纳入和排除标准,对分布在23个国家的53篇文章(3593株大环内酯类耐药和15951株敏感分离株)进行了剖析,其中高收入国家的文章占主导地位,低收入国家的文章较少。尽管GAS中的大环内酯类耐药性在不同国家差异很大,但其在GAS内的分布似乎并非随机。emm模式E、13种主要emm型(emm12、4、28、77、75、11、22、92、58、60、94、63、114)和4个emm簇(A-C4、E1、E6和E2)与大环内酯类耐药性显著相关。emm模式A-C和D、14种主要emm型(emm89、3、6、2、44、82、87、118、5、49、81、59、227、78)和3个明确的emm簇(A-C5、E3和D4)与大环内酯类敏感性显著相关。仔细研究每种MRGAS emm型与特定大环内酯类耐药表型或基因型显著相关的趋势,也揭示了一些有趣的情况。30价疫苗覆盖约95%的MRGAS分离株。所呈现的数据凸显了在全国范围内对MRGAS流行克隆进行全面持续监测的重要性,特别是在低收入和中等收入国家,那里抽样偏差很大,GAS流行病学模糊不清,需要揭开其神秘面纱。

相似文献

1
A global snapshot on the prevalent macrolide-resistant emm types of Group A Streptococcus worldwide, their phenotypes and their resistance marker genotypes during the last two decades: A systematic review.全球范围内A群链球菌大环内酯类耐药emm型的流行情况、表型及其在过去二十年中的耐药标记基因型的总体概况:一项系统综述。
Infect Genet Evol. 2022 Apr;99:105258. doi: 10.1016/j.meegid.2022.105258. Epub 2022 Feb 24.
2
emm Types and clusters and macrolide resistance of pediatric group A streptococcal isolates in Central Greece during 2011-2017.2011-2017 年希腊中部地区儿科 A 组链球菌分离株的类型、聚类和大环内酯类耐药性。
PLoS One. 2020 May 7;15(5):e0232777. doi: 10.1371/journal.pone.0232777. eCollection 2020.
3
Molecular characterization of macrolide resistant Streptococcus pyogenes isolates from pharyngitis patients in Serbia.塞尔维亚咽炎患者中耐大环内酯类化脓性链球菌分离株的分子特征分析
Infect Genet Evol. 2015 Jul;33:246-52. doi: 10.1016/j.meegid.2015.05.011. Epub 2015 May 12.
4
Molecular emm typing of Bulgarian macrolide-resistant Streptococcus pyogenes isolates.保加利亚大环内酯类耐药化脓性链球菌分离株的分子emm分型
Acta Microbiol Immunol Hung. 2019 Dec 13;67(1):14-17. doi: 10.1556/030.66.2019.033.
5
Macrolide antibiotics for bronchiectasis.用于支气管扩张症的大环内酯类抗生素
Cochrane Database Syst Rev. 2018 Mar 15;3(3):CD012406. doi: 10.1002/14651858.CD012406.pub2.
6
Antibiotics for exacerbations of asthma.用于哮喘加重期的抗生素
Cochrane Database Syst Rev. 2018 Jun 25;6(6):CD002741. doi: 10.1002/14651858.CD002741.pub2.
7
Molecular analysis of Streptococcus pyogenes macrolide resistance of paediatric isolates during a 7 year period (2007-13).7年期间(2007 - 2013年)儿童分离出的化脓性链球菌大环内酯类耐药性的分子分析
J Antimicrob Chemother. 2016 Aug;71(8):2113-7. doi: 10.1093/jac/dkw116. Epub 2016 Apr 26.
8
Seven-year surveillance of emm types of pediatric Group A streptococcal pharyngitis isolates in Western Greece.希腊西部儿科 A 组链球菌咽炎分离株 emm 型的 7 年监测。
PLoS One. 2013 Aug 19;8(8):e71558. doi: 10.1371/journal.pone.0071558. eCollection 2013.
9
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
10
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.

引用本文的文献

1
A Review of the Impact of Streptococcal Infections and Antimicrobial Resistance on Human Health.链球菌感染及抗菌药物耐药性对人类健康影响的综述
Antibiotics (Basel). 2024 Apr 15;13(4):360. doi: 10.3390/antibiotics13040360.
2
SIgA structures bound to Streptococcus pyogenes M4 and human CD89 provide insights into host-pathogen interactions.与酿脓链球菌 M4 和人 CD89 结合的 SIgA 结构提供了宿主-病原体相互作用的见解。
Nat Commun. 2023 Oct 23;14(1):6726. doi: 10.1038/s41467-023-42469-y.